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Glial Cell Extracellular Matrix in Alzheimer's Disease David Many studies have yielded conflicting results regardi~g the toxic~ty of ~ [3, the peptide which is the principal coml?on~nt <:,f senile. pla~ues III brams of patients with Alzheimer's disease. Usmg m mtra and zn ~zvo models, ~e have studied the role of glial cells and extracellular matnx molecules m mediating the effects of A [3. Glial cells respond to A[3 substrate by accumulating and depositing chondroitin sulfate proteoglycans (CSPGs) which are inhibitory to neurite outgrowth. CSPGs are present around the senile plaque core, an area with both dystrophic neurites an~ a general decrease in normal neurites. We suggest that CSPG may contnbute to the pathology by leading to regenerative failure of neurites surrounding senile plaques.
ASTROCYTIC REACTION TO BRAIN INJURY Generalized Gliosis
Classical observations by Cajal in the early part of this century described the changes associated with astrocytes following trauma and diseases of the CNS. 1 This became known as gliosis and can be defined as the 158 
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response of glia to local injury with a characteristic change in morphology of the responding cells. Such reactive cells assume ramified .
. 23 processes and develop pronounced hypertrophy and hyperplasIa. ' However, astrocytic response to injury· is somewhat heterogeneous. For instance, following a penetrating injury to the cerebral cortex, astrocytes proximal and distal to the lesion demonstrate elevated levels of glial fibrillary acidic protein and therefore are defined as gliotic. 4 However, astrocytes closer to the site of injury are phenotypically different to those that are more distaL Astrocytes surrounding a penetrating injury in the cortex exhibit hyperplasia as well as hypertrophy, whereas astrocytes away from the injury site show almost exclusively hypertrophy.5,6 Moreover, it has been shown that only the astrocytes surrounding the actual injury site express vimentin, and markers which suggest these cells are undergoing localized proliferation. 6 It is generally believed that reactive gliosis is the main impediment to the regenerative efforts of the adult mammalian CNS.7 Such a view is supported by the experiments of Aguayo and collaborators who demonstrated. that mature neurons of the CNS retain the ability to regrow so long as the environment contains elements which provide a favorable substrate and support the growth of neuronal processes. However, outgrowth will not occur if the environment presented to the regenerating axonal process is non-permissive or contains actively inhibitory elements. In such a way, regenerating CNS neurons can extend a..xons into the regeneration-promoting areas of peripheral nerve grafts, but fail to penetrate into the regions where reactive gliosis forms a glial scar. 8 -12 Production of ECM Proteins While it is established that the cells and matrices of glial scars represent a barrier to axon regeneration, it is still controversial whether it is the cells themselves or molecules of the extracellular matrix which prevent process outgrowth. Glial scars 13 consist of a dense meshwork of hypertrophied astrocytic processes and their associated molecular matrices 13 -15 which together present a tortuous path for migrating growth cones. Although the physical presence of the glial scar creates a mechanical barrier that limits axon growth, changes in the molecular properties of reactive astrocytes associated with a scar could also contribute to regenerative failure. 16 A decrease in growth promoting molecules l7 ,lB or a local upregulation of axon inhibitory molecules by glia 19 could also diminish regeneration. Many molecules of the extracellular matrix play important roles during development of the nervous system and in homeostatic control of the CNS.20,21 Synthesis and modification of extracellular matrix components by reactive glial cells may be one of the most important features of the response of the CNS to injury and disease.
Astrocytes respond to wounds in the central nervous system by the production of growth factors and various ECM proteins. In addition, microglia, in regions of neurodegeneration, secrete IL_122 which can induce TGF~ production and possibly ECM accumulation by astrocytes. 23 Tenascin and laminin are among several glycoproteins increased at wound sites_ 24 Laminin in particular is one of the most potent neurite outgrowth promoting molecules that exists. Tenascin can be both growth promoting or growth inhibiting depending on the presence of associated molecules. 25 Even though the glial scar produces these and other factors that could encourage regeneration, nevertheless, it remains an obstacle to neurite outgrowth. Perhaps, the presence of growth inhibitory molecules can negate the facilitory effects of these factors.
Many believe that astrocytes respond to mechanical wounds through the formation of a glial scar in order to re-establish a compromised glial limitans. Proteoglycans are a m"yor component of the gliallimitans and it has been demonstrated that proteoglycans are markedly increased in regions of reactive gliosis due to trauma. 19 ,26,27 In vitro experiments have shown that proteoglycans can be potent inhibitors of neurite outgrowth. 28 ,29 Thus, their enhanced presence in the glial scar could play a m,yor role in regenerative failure. This same kind of "walling off' response by astrocytes also appears to occur around SPs in AD.
Glial Cells Associated with Senile Plaques in AD
Senile plaques consist of a dense core of amyloid f)-protein (A[3), a 40-42 amino acid peptide derived from a larger precursor, J3PP. 30 Microglial cells are found throughout the senile plaque. The specific role of microglia is unknown although they might be responsible for AJ3 .i
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generation from J3PP. Others have suggested a more active role through the generation of complement attack complexes. 3l Surrounding the AJ3 core are many dystrophic neurites and processes of reactive astrocytes. Presumably, the cause of astrocyte reactivity is the extensive neuronal death which occurs throughout the AD brain or their reaction to A[3.
However, a more active role for astrocytes has generally been overlooked 32 and indeed, astrocytes could contribute to the pathology of the disease by altering the local environment to one that compromises neuronal viability.
GLIAL REACTION TO AMYLOID J)-PROTEIN (AJ3)
In Vitro Studies
The fmding that AJ3 is normally produced and is found in a soluble .c 33 .
10rm came as a surpnse to many researchers who viewed AJ3 as an unwanted, toxic, insoluble byproduct resulting from aberrant proteolysis. Therefore, the key event in SP formation may not be the generation of AJ3 per se, but rather factors that promote the accumulation of AJ3. The cellular responses to A~ are presently being defined and many conflicting studies have shown that A/3 is toxic or trophic to neurons depending on the experimental conditions. 34 ,35 Much of the confusion of A/3 toxicity may be the result of parameters and factors other than A!3.
AJ3 may not have a direct effect on neurons; instead, it may act indirectly by affecting other cells or ~ducing the accumulation of other molecules which are themselves harmful to neurons. Our approach has been to determine whether glial cells may be involved and whether molecules secondary to A~ may affect neurons. In an in vitro mode]36 A!3 is bound to specific areas on a tissue culture dish and used as a substrate for ceUs. Since AJ3 in the SPs is insoluble substrate bound A~ may simulate SP-AJ3 better than A!3 added to cultur~ media. Neurons show a preferential adherence to AJ3 and laminin together over laminin alone, corroborating another report suggesting that A!3 enhances the growth promoting activity oflaminin. 37 Astrocytes, on the other hand, change morphology, become highly motile, and Increases in specific glycosaminoglycans were initially reported in extracts made from the brains of Alzheimer's disease patients. 42 Later, use of cationic dyes such as Alcian blue showed that glycosaminoglycans are associated with senile plaques (SP). 43 Further experimental approaches using a basic fibroblast grotvth factor (bFGF) binding assay indicates heparan sulfate proteoglycans (HSPG) in amyloid deposits, dystrophic neurites around SPs and extracellular NFTs. 44 ,45 Immunocytochemical experiments indicate that the HSPG in SPs may be perle can, the basement membrane HSPG. 46 Chondroitin sulfate proteoglycans show a different distribution than HSPG.40 vVhile HSPG is found throughout the SP, CSPG is found only in the periphery, surrounding the Aj3 core. CSPG is also present in intracellular NFTs and dystrophic neurites as well as reactive astrocytes in the vicinity of senile plaques. 36 Dermatan sulfate proteoglycan is also present in the SP periphery. 47 In addition to proteoglycans, several other ECM proteins are found in SPs including fibronectin,48 laminin,49 and collagen type IV.49 These ECM molecules are neurite outgrmv1:h promoting molecules, and were hypothesized to promote neurite outgrowth and sprouting in the SP. Indeed, several studies report increased and aberrant sprouting of neurites in SPs. These findings support the idea of trophic effects of Aj3 and localization of growth factors in the SP.
ECM-related molecules are also present in SPs including proteases and protease inhibitors that are involved in the degradation and protection of ECM molecules. al-antichymotrypsin, al-antitrypsin, anti-thrombin III, protease nexin I, and other protease inhibitors have been identified. 50 Proteases including trypsin,51 chymotrypsin, 52 and Fig. 13.2 A. bFGF binds to heparanase sensitive sites in senile plaques of Alzheimer's disease. B. Chondroitin 6-sulfate proteoglycan is found in the periphery, surrounding the Aj3 core. metalloprotease 9 53 have also been localized to SP. One recent hypothesis suggests that a proteolytic imbalance occurs in the area of a SP. 54 The accumulation of ECM proteins in SPs might be the result of decreased matrix turnover. Indeed, the presence of TGF~55 in SPs could 60 demonstrated that the density of normal neurites was reduced around SPs. Reduced neurite density occurred not only in the A~ core as would be expected but also up to twO plaque core distances away. Surprisingly, some normal neurites curve around the SP periphery. This suggests that the SP environment, in addition to causing neuritic dystrophy, may somehow prevent or reduce normal neurites in this area.
Neuronal Sprouting?
Another hypothesis for the cause of neuritic dystrophy is aberrant sprouting of neurons. 61 Many growth factors and growth promoting molecules have been found in SPs including bFGF,62 laminin and collagen. Growth associated proteins such as GAP43 63 and NTP64 have been identified in neurites of SPs. \-Vhile it has been suggested that excessive or abnormal sprouting of neurites due to increased trophism may cause neuritic dystrophy, the relation of these molecules to regeneration has not been overlooked. 55 Indeed, GAP43 and the other growth promoting/associated molecules are all characteristic of wound or regeneration related molecules.
This suggests a different view of the neurites and ECM proteins in SPs. Instead of a growth promoting, trophic environment for excessive neurite outgrowth, the SP may prevent the restoration of synapses by inhibiting neuritic infiltration into the area. Such an idea is supported by the bulbous, dystrophic neurites found in A~ deposits of AD brain which differ from degenerating neurites found in other neurological conditions 66 and are not characterized by large, focal, extracellular deposits of wound related molecules_
Why is there a Halo?
Further evidence suggests that the periphery around the SP, rather than the core itself, has the greatest impact on neurons. When retinal ganglion cells are grown on cryostat sections of AD brain 67 they attach and put forth processes. No difference in the density of neurons which attach to SP cores and those which attach to areas lacking SPs is noted. However, the number which adhere to the periphery of SPs was substantially decreased. In addition, grow-th in this peri-plaque region is inhibited and neurons are more likely to extend a process away rather than toward SPs. Some neurons were obseIVed which initially grow toward a SP but then CUIVe and turn away. These results are consistent with the observations of a lack of normal neurites in the periphery of SPs.
As neurons die throughout the brain in AD, there may be an attempt to recover some of the lost synapses through collateral sprouting. Astrocytic deposition of CSPG may impact this process by inhibiting neurite outgrowth, thus preventing the sprouts from reaching their potential targets. Therefore, while the number of synapses, neurons, and neurite density decreases throughout the brain in AD, attempts at recovery are possible except in the area of the periphery of the SP where CSPG prevents neuritic outgrowth as well as synaptic restoration. Synapse loss is accentuated in SPs, but not in diffuse SPs where there is no distinction from the rest of the neuropil. 68 Interestingly, diffuse SPs do not have CSPG accumulation. Therefore, the presence of CSPG is correlated with increased synaptic pathology in the AD brain. In this chapter we review the findings indicating that complement activation in amyloid plaques does not proceed further than C3. The idea is discussed that in Alzheimer's disease, complement does not function as an inflammatory mediator through membrane attack complex formation, but through the action of early complement activation products.
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